Intraoperative Administration of Intravenous Morphine in Patients Undergoing Laparoscopic Cholecystectomy
Intraoperative Administration of Intravenous Morphine in Patients Undergoing Laparoscopic Cholecystectomy - a Retrospective, Observational, Quality-improvement Study
Esbjerg Hospital - University Hospital of Southern Denmark
300 participants
Jun 1, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this observational, quality improvement study is to compare the effect of a dose of morphine given during gall-bladder removal surgery. The main questions to answer are: * Do participants, who are given given a dose of morphine during gall-bladder removal surgery, experience less pain after surgery? * Does a dose of morphine during gall-bladder removal surgery cause more side effects? The investigators will compare the effects of two types of anesthesia: a) anesthesia without morphine during surgery, and b) anesthesia with morphine during surgery.
Eligibility
Inclusion Criteria1
- patients who have had elective laparoscopic cholecystectomy/planned gall-bladder removal surgery
Exclusion Criteria6
- age limit as above
- patients unable to give consent to anesthesia
- patients unable to participate in pain scoring
- patients with chronic pain syndromes, characterized by patients receiving regular analgesic treatment and patients with active or previous contact to pain clinic)
- patients with active or previous substance abuse
- emergency surgery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Morphine dose = 0,1 mg mg/kg (maximum 10 mg) intravenous given 20 min after start of surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06182111